<DOC>
	<DOCNO>NCT00239304</DOCNO>
	<brief_summary>To determine safety tolerability gefitinib combination cisplatin radiation ( 3D-CRT IMRT ) patient locally advanced head neck cancer .</brief_summary>
	<brief_title>Gefitinib ( Iressa ) Combo With Chemoradiation Patients With Locally Advanced Head &amp; Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically confirm head neck cancer Lymph node negative positive Metastasis negative Chemo radiotherapy na√Øve WHO 02 Measurable disease RECIST Written inform consent Severe alcohol abuse Active ILD Coexisting chronic gastrointestinal disease ( ) Brain metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Stage III Head Neck Cancer</keyword>
	<keyword>Stage IV Head Neck Cancer</keyword>
</DOC>